Vasomune Therapeutics

Vasomune Therapeutics Overview

Founded 2012
Status Private
Employees 3
Latest Deal Type Seed
Latest Deal Amount $1.5M
Latest Deal Amount
Investors 3

Vasomune Therapeutics General Information


Developer of biotechnology platform intended to help with the treatment of target diseases associated with vascular dysfunction and destabilization. The company's drug candidate targets a signaling molecule in the vasculature responsible for regulating barrier defense and the host vascular response to injury enabling doctors to help patients to fight against illness by modifying the cellular response to disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 180 John Street
  • Suite 305
  • Toronto, Ontario M5T 1X5
  • Canada
+1 (647) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vasomune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 20-Oct-2014 $1.5M 00.00 Completed Product Development
1. Grant 01-Apr-2014 0000 Completed Product Development

Vasomune Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Douglas Hamilton Chief Executive Officer & President
Steven Chackowicz Executive
Parimal Nathwani Chairman

3 Former Executives

Vasomune Therapeutics Board Members (6)

To view Vasomune Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Meenu Chhabra Self Board Member 000 0000
Michael Young Self Board Member 000 0000
Niclas Stiernholm Ph.D Self Board Member 000 0000
Parimal Nathwani Self Chairman 000 0000
Raphael Hofstein Ph.D Toronto Innovation Acceleration Partners Board Member 000 0000

1 Former Board Member

Vasomune Therapeutics Investors (3)

To view Vasomune Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ontario Genomics Corporation Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital 000 0000 000000 0

Ready to get started?

Request a free trial